title: Effect of lyophilization on the in vitro biological activity of bevacizumab.
authors.forename: L
authors.initials: L
authors.lastname: Taniwaki
authors.forename: R
authors.initials: R
authors.lastname: Mendonça
authors.forename: A S
authors.initials: AS
authors.lastname: Cunha-Júnior
authors.forename: A A G
authors.initials: AA
authors.lastname: Faraco
authors.forename: J A S
authors.initials: JA
authors.lastname: Ribeiro
authors.forename: I U
authors.initials: IU
authors.lastname: Scott
authors.forename: R
authors.initials: R
authors.lastname: Jorge
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004355:Drug Stability; D005612:Freeze Drying; D011309:Preservation, Biological / Q000379:methods*; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab